CD8A and neoplasm: NEAT1 acts as a ceRNA in oncogenic cells, targeting miR-101-3p and enhancing the expression of ZEB1, resulting in the proliferation of ovarian cancer cells, tumour growth and apoptosis of CD8+ cells via miR-101-3p/ZEB1/PD-L1 pathway (Yin and Wang, 2023).